Letters to the Editor

The improved prognosis of FLT3-internal tandem duplication but not tyrosine kinase domain mutations in acute myeloid leukemia in the era of targeted therapy: a real-world study using large-scale electronic health record data

Department of Oncology, Swedish Cancer Institute, Seattle, Washington; Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois
Division of Blood and Marrow Transplant and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford
Technology and Digital Solutions (TDS), Research Technology, and Research Data Services at Stanford Health Care and School of Medicine, Stanford
Technology and Digital Solutions (TDS), Research Technology, and Research Data Services at Stanford Health Care and School of Medicine, Stanford
Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, Stanford
Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, Stanford, California; Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford
Division of Hospital Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, California; Stanford Center for Biomedical Informatics Research, Stanford University, Stanford, CA; Clinical Excellence Research Center, Stanford University, Stanford, CA
Stanford University, Center for Health Policy, Stanford University School of Medicine, California; Division of Primary Care and Population Health, Department of Medicine, Stanford University School of Medicine, Stanford
Division of Hematology, Department of Medicine, Stanford University School of Medicine, Stanford, California; Cancer Institute, Stanford University School of Medicine, Stanford
Haematologica Early view Feb 6, 2025 https://doi.org/10.3324/haematol.2024.286695